[ConservativeMind]

“These improvements—as measured by a significantly lower annualized rate of acute exacerbations, significantly better lung function and quality of life, and significantly less severe symptoms than placebo-treated adults with COPD—were observed within two to four weeks after the initiation of dupilumab and were sustained throughout the 52-week trial period.”

That’s a big deal.

[ConservativeMind]

The “Take Charge Of Your Health” Ping List
This high volume ping list is for health articles and studies which describe something you or your doctor, when informed, may be able to immediately implement for your benefit.

Email me to get on either the “Common/Top Issues” (20 - 25% fewer pings) or “Everything” list.

[Rumplemeyer]

BUMP

[ssfromla]

That’s a big deal

A very big deal. I need some of that yesterday.

It's a horrible disease to have.

[HandyDandy]

Bookmark

[Gil4]

according to a yearlong, Phase 3 clinical trial

Does anyone here know the process? Is this something that is close to use or is it still years away and unlikely to make it to market?

[OftheOhio]

I’ve always wondered about the selection process for the placebo-treated victims.

https://www.askapatient.com/viewrating.asp?drug=761055&name=DUPIXENT

[BozoTexino]

Bookmark for Mike.

[muggs]

Thank you!